MedPath
HSA Product

NOVORAPID FLEXPEN INJECTION 100 u/ml

Product approved by Health Sciences Authority (SG)

Basic Information

NOVORAPID FLEXPEN INJECTION 100 u/ml

INJECTION

Regulatory Information

SIN12189P

February 6, 2003

Prescription Only

Therapeutic

INTRAVENOUS, SUBCUTANEOUS

August 10, 2023

May 30, 2025

XA10AB05

Company Information

NOVO NORDISK PHARMA (SINGAPORE) PTE LTD

NOVO NORDISK PHARMA (SINGAPORE) PTE LTD

Active Ingredients

Insulin Aspart

Strength: 100 u/ml

Detailed Information

Contraindications

**Contraindications** Hypersensitivity to the active substance or any of the excipients.

Indication Information

**Therapeutic indications** Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.

© Copyright 2025. All Rights Reserved by MedPath